Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation
Haibo Xie, Chunrong Li, Hua Tang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2904-2917
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The Magic Methyl and Its Tricks in Drug Discovery and Development
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Carlos Alberto Manssour Fraga
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1157-1157
Open Access | Times Cited: 42
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 35
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 27
Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation
Stephen H. Norris, Xiaochu Ba, Jayce Rhodes, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16388-16409
Closed Access | Times Cited: 22
The cyclimids: Degron-inspired cereblon binders for targeted protein degradation
Saki Ichikawa, N. Connor Payne, Wenqing Xu, et al.
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1162-1175.e10
Open Access | Times Cited: 10
Molecular glue degraders: exciting opportunities for novel drug discovery
Thomas Lemaître, Marie Cornu, Florian Schwalen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 433-449
Closed Access | Times Cited: 8
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs
Christian Steinebach, Aleša Bricelj, Arunima Murgai, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14513-14543
Open Access | Times Cited: 15
PROTACs Targeting MLKL Protect Cells from Necroptosis
Oliver H. Rathje, Lara Perryman, Richard J. Payne, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11216-11236
Closed Access | Times Cited: 13
Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACs
Marisa Actis, Joel O. Cresser-Brown, Elizabeth A. Caine, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Synthesis of α-(azidomethyl)glutarimide and its applicationin construction of potential Cereblon ligands <em>via</em> the CuAAC reaction
Liliya R Khuzhakhmetova, Anna Alekseevna Ananeva, Grigory Kantin, et al.
Mendeleev Communications (2025) Vol. 35, Iss. 1, pp. 69-72
Closed Access
Catalytic Castagnoli--Cushman reaction-based synthesis of tetrahydroisoquinolone--glutarimide dyads and their evaluation as potential cereblon ligands
Anna Alekseevna Ananeva, Grigory Kantin, Dmitry Dar’in, et al.
Mendeleev Communications (2025) Vol. 35, Iss. 3, pp. 285-288
Closed Access
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors
Haiting Duan, Jingyu Zhang, Renzhao Gui, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11326-11353
Closed Access | Times Cited: 4
Discovery of novel benzosultam CRBN ligands
Hoyeong Park, Santosh Shivanand Raikar, Yonghyo Kim, et al.
Bulletin of the Korean Chemical Society (2025)
Closed Access
Exploration of Hydrazide-Based HDAC8 PROTACs for the Treatment of Hematological Malignancies and Solid Tumors
Chunlong Zhao, Jianqiu Zhang, Hangyu Zhou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14016-14039
Open Access | Times Cited: 3
Facilitating the development of molecular glues: Opportunities from serendipity and rational design
Weiqing Jiang, Yunhan Jiang, Youfu Luo, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115950-115950
Closed Access | Times Cited: 8
Asymmetric Dirhodium-Catalyzed Modification of Immunomodulatory Imide Drugs and Their Biological Assessment
William F. Tracy, Geraint H. M. Davies, Lei Jia, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1575-1583
Open Access | Times Cited: 2
Property-based optimisation of PROTACs
James S. Scott, Iacovos N. Michaelides, Markus Schade
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
A Modular Chemistry Platform for the Development of a Cereblon E3 Ligase‐Based Partial PROTAC Library
Chelsi M. Almodóvar‐Rivera, Zhen Zhang, Jingyao Li, et al.
ChemBioChem (2023) Vol. 24, Iss. 20
Open Access | Times Cited: 4
Discovery and characterization of potent spiro-isoxazole-based cereblon ligands with a novel binding mode
Robert Shevalev, Luca Bischof, Alexander Sapegin, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116328-116328
Closed Access | Times Cited: 1
Design, synthesis, and bioevaluation of SOS1 PROTACs derived from pyrido[2,3-d]pyrimidin-7-one-based SOS1 inhibitor
Kun Wang, Zehui Zhou, Xinyi Ma, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 107, pp. 129780-129780
Closed Access | Times Cited: 1
Tactics and Strategies for the Synthesis of Cereblon Ligands
Elisia Villemure, Christian Nilewski, Yong Wang, et al.
Synthesis (2024) Vol. 56, Iss. 23, pp. 3543-3554
Closed Access | Times Cited: 1
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs
Christian Steinebach, Izidor Sosič, Aleša Bricelj, et al.
(2023)
Open Access | Times Cited: 2
Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development
Mark S. Cooper, Mark C. Norley, S Armitage, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 41, pp. 8344-8352
Closed Access | Times Cited: 2
5-Diazo Dihydrouracils: Preparation and Some Transformations
Grigory Kantin, Alexander Sapegin, Dmitry Dar’in
The Journal of Organic Chemistry (2024)
Closed Access
One-Step Regioselective Synthesis of N-1-Substituted Dihydrouracils: A Motif of Growing Popularity in the Targeted Protein Degradation Field
Ian D. G. Nixon, Joseph M. Bateman, Iacovos N. Michaelides, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 24, pp. 18301-18312
Closed Access
Page 1 - Next Page

Scroll to top